Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3067% below fair value
$171.41−17.78 (-9.40%)
Close on Nov 12, 2026Market cap $1.17BP/E 7.3Yield –
Nutex Health statistics
101 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 4, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.92
- 4.88
- P/OCF Ratio
- 4.54
- 13.16
Enterprise valuationIndustry
- EV / Sales
- 1.35
- 2.03
- EV / EBIT
- 3.45
- 20.87
- EV / FCF
- 4.32
- 15.27
Share statisticsIndustry
- Shares Change (YoY)
- 5.22%
- 1.97%
- Shares Change (QoQ)
- 0.20%
- 0.07%
- Shares Held by Institutions
- 42.9%
- 62.8%
Short sellingIndustry
- Short Interest
- 1M
- –
- Short Interest Change
- -5.86%
- -3.30%
- Short % of Shares Outstanding
- 17.0%
- 4.22%
- Days to Cover
- 10.09
- 3.54
Stock price statisticsIndustry
- 52-Week High
- $226.16
- –
- 52-Week Low
- $83.99
- –
- 20-Day Moving Average
- $195.77
- –
- 50-Day Moving Average
- $202.78
- –
- 200-Day Moving Average
- $151.89
- –
- Average True Range (14)
- $14.36
- –
- Price Change (1 Week)
- -11.5%
- 0.35%
- Price Change (1 Month)
- -13.0%
- 0.00%
- Price Change (3 Months)
- -8.54%
- -7.14%
- Price Change (6 Months)
- 34.1%
- 0.66%
- Price Change (YTD)
- 4.12%
- -14.1%
- Price Change (1 Year)
- 53.1%
- -14.0%
- Price Change (3 Years)
- 355.1%
- -12.6%
- Price Change (5 Years)
- -73.4%
- -56.7%
- Average Volume (10 Days)
- 158,566
- –
- Average Volume (20 Days)
- 137,339
- –
- Average Volume (90 Days)
- 147,836
- –
- Relative Volume
- 1.34
- 0.71
- Relative Strength Index (14)
- 39.0
- 47.3
- Volatility (1 Year)
- 91.0%
- 65.3%
- Beta (5 Years)
- 1.84
- 1.19
MarginsIndustry
- Pretax Margin
- 36.7%
- -0.63%
- EBITDA Margin
- 41.8%
- 0.85%
- FCF Margin
- 31.1%
- 9.88%
Returns on capitalIndustry
- Return on Equity (ROE)
- 43.8%
- 1.34%
- Return on Assets (ROA)
- 16.5%
- -3.12%
- Return on Invested Capital (ROIC)
- 117.4%
- -0.29%
- Return on Capital Employed (ROCE)
- 34.6%
- -0.55%
Financial positionIndustry
- Current Ratio
- 4.76
- 1.37
- Quick Ratio
- 1.88
- 0.93
- Debt / Equity
- 0.10
- 0.52
- Debt / EBITDA
- 0.13
- 2.60
- Debt / FCF
- 0.17
- 2.79
- Net Debt / EBITDA
- -0.62
- 1.41
- Interest Coverage
- 16.21
- -0.55
GrowthIndustry
- Revenue Growth (YoY)
- -18.8%
- 9.45%
- Net Income Growth (YoY)
- 36.5%
- 9.41%
- EPS Growth (YoY)
- 21.2%
- 12.4%
- FCF Growth (YoY)
- 40.7%
- 14.5%
- Revenue Growth (3Y CAGR)
- 58.6%
- 7.44%
- Revenue Growth (5Y CAGR)
- 26.1%
- 12.3%
- EPS Growth (5Y CAGR)
- -17.2%
- 12.4%
EfficiencyIndustry
- Asset Turnover
- 0.80
- 0.64
- Inventory Turnover
- 100.18
- 13.86
- Revenue Per Employee
- $843.78K
- $396.32K
- Profits Per Employee
- $174.48K
- -$6.68K
- Employee Count
- 944
- 525
- WACC
- 14.0%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- $292.08M
- -$294.07K
Balance sheetIndustry
- Net Cash (Debt)
- $207.61M
- $1.79M
- Net Cash Per Share
- $30.32
- $0.13
- Equity (Book Value)
- $435.57M
- $51.00M
- Book Value Per Share
- $63.61
- $1.99
- Tangible Book Value
- $401.39M
- $2.78M
- Working Capital
- $500.30M
- $14.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$10.35M
- -$5.59M
- FCF Per Share
- $36.23
- $0.53
Dividends and yieldsIndustry
- Earnings Yield
- 14.0%
- 0.38%
- FCF Yield
- 21.1%
- 4.32%
- Buyback Yield
- 4.74%
- 3.37%
- Shareholder Yield
- 4.74%
- 3.80%
Taxes and interestIndustry
- Interest Expense
- $19.19M
- $3.48M
- Income Tax
- $59.05M
- $1.62M
- Effective Tax Rate
- 20.2%
- 22.3%
Scores and fair valueIndustry
- Graham Number
- $182.80
- $16.66
- Graham Upside
- 6.65%
- -55.3%
- Altman Z-Score
- 3.60
- 1.97
- Piotroski F-Score
- 7
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NUTX | S&P 500 | Difference | NUTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -16.9% | -2.7% | −14.2 pts | ||
| 3 months | -0.6% | -1.7% | +1.1 pts | ||
| Year to date | +4.1% | +11.9% | −7.8 pts | ||
| 1 year | +40.9% | +12.0% | +28.9 pts | ||
| 3 years | +376.2% | +78.2% | +298.0 pts | +68.2% | +21.2% |
| 5 years | -73.4% | +73.2% | −146.7 pts | -23.3% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M NUTX shares were sold short on Oct 30, 2026, down 5.9% from the previous report. At recent volumes it would take 10.1 days to buy them back. Over the last 20 sessions, 65.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,164,595 | -5.9% | 115,422 | 10.1 |
| Oct 15, 2026 | 1,237,099 | -1.1% | 163,561 | 7.6 |
| Sep 30, 2026 | 1,250,508 | +1.3% | 152,597 | 8.2 |
| Sep 15, 2026 | 1,234,054 | +6.2% | 164,069 | 7.5 |
| Aug 31, 2026 | 1,162,501 | +2.9% | 134,426 | 8.7 |
| Aug 14, 2026 | 1,130,121 | +2.3% | 193,890 | 5.8 |
| Jul 31, 2026 | 1,104,332 | +5.2% | 122,158 | 9.0 |
| Jul 15, 2026 | 1,049,917 | -5.1% | 137,851 | 7.6 |
| Jun 30, 2026 | 1,106,860 | -0.8% | 123,287 | 9.0 |
| Jun 15, 2026 | 1,115,541 | +4.7% | 134,170 | 8.3 |
| May 29, 2026 | 1,065,264 | +16.3% | 124,262 | 8.6 |
| May 15, 2026 | 916,308 | -8.1% | 181,881 | 5.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?